Why it matters
The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
Project record
At a glance
- Company
- Eli Lilly
- Industry
- Pharmaceuticals
- Location
- Huntsville, Alabama
- Investment
- $6.00B
- Permanent jobs announced
- 450
- Status
- Planning
- Announced
- Dec 9, 2025
- Expected opening
- Jan 1, 2032
- Added to tracker
- Feb 11, 2026
Sources
Official references
- Primary source https://investor.lilly.com/news-releases/news-release-details/lilly-build-6-billion-facility-manufacture-active-pharmaceutical
Related
Other projects to know
In Alabama
Back to the tracker/projects/eli-lilly-huntsville